Structure‐Based Development of a Covalent Inhibitor Targeting Streptococcus Pyogenes over Staphylococcus Aureus Sortase A
- 24 March 2025
- journal article
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (23) , e202500464
Abstract
Sortase A (SrtA), a cysteine transpeptidase critical for surface protein anchoring in Gram‐positive pathogens, represents an attractive antivirulence target. While covalent SrtA inhibitors show therapeutic potential, existing compounds lack species selectivity. Through structure‐guided design, we developed T10, a covalent inhibitor selectively targeting Streptococcus pyogenes SrtA (SpSrtA) over Staphylococcus aureus SrtA (SaSrtA). Molecular docking revealed that shortening a “C=C” bond in lead compound ML346 eliminated SaSrtA inhibition due to steric hindrance from W194, while maintaining SpSrtA binding. X‐ray crystallography confirmed T10′s covalent modification of Cys208 in SpSrtA. T10 demonstrated two fold enhanced inhibitory potency and species‐specific disruption of M‐protein anchoring and biofilm formation in Streptococcus pyogenes, without affecting Staphylococcus aureus viability. In a Galleria mellonella infection model, T10 conferred potent protection against lethal infection. This work demonstrates the development of narrow‐spectrum antivirulence agents through a structure‐based rational strategy.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFC2705005, 2023YFD1800102)
- National Natural Science Foundation of China (81861138046, 22107109)
This publication has 38 references indexed in Scilit:
- Structure-Guided Design, Synthesis, and Antivirulence Assessment of Covalent Staphylococcus aureus Sortase A InhibitorsJournal of Medicinal Chemistry, 2024
- Discovery of Sortase A covalent inhibitors with benzofuranene cyanide structures as potential antibacterial agents against Staphylococcus aureusEuropean Journal of Medicinal Chemistry, 2022
- Sortase A (SrtA) inhibitors as an alternative treatment for superbug infectionsDrug Discovery Today, 2021
- Anchoring surface proteins to the bacterial cell wall by sortase enzymes: how it started and what we know nowCurrent Opinion in Microbiology, 2021
- Targeting Bacterial Sortase A with Covalent Inhibitors: 27 New Starting Points for Structure-Based Hit-to-Lead OptimizationACS Infectious Diseases, 2019
- Quinone skeleton as a new class of irreversible inhibitors against Staphylococcus aureus sortase ABioorganic & Medicinal Chemistry Letters, 2018
- Expanding the Scope of Sortase‐Mediated Ligations by Using Sortase HomologuesChemBioChem, 2017
- Sortase A: An ideal target for anti-virulence drug developmentMicrobial Pathogenesis, 2014
- The streptococcal M protein: a highly versatile moleculeTrends in Microbiology, 2010
- Surface protein adhesins of Staphylococcus aureusTrends in Microbiology, 1998